Literature DB >> 28656493

CORR Insights®: Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

Daniel R Whiting1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28656493      PMCID： PMC5539052          DOI： 10.1007/s11999-017-5435-1

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  12 in total

1.  Does anticoagulation do more harm than good?: A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty.

Authors:  Raymond A Sachs; Jennifer H Smith; Mary Kuney; Liz Paxton
Journal:  J Arthroplasty       Date:  2003-06       Impact factor: 4.757

2.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients.

Authors:  M D Stringer; C A Steadman; A R Hedges; E M Thomas; T R Morley; V V Kakkar
Journal:  J Bone Joint Surg Br       Date:  1989-05

4.  Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.

Authors:  Javad Parvizi; Ronald Huang; Camilo Restrepo; Antonia F Chen; Matthew S Austin; William J Hozack; Jess H Lonner
Journal:  J Bone Joint Surg Am       Date:  2017-01-18       Impact factor: 5.284

Review 5.  Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.

Authors:  D G G Wilson; W E C Poole; S K Chauhan; B A Rogers
Journal:  Bone Joint J       Date:  2016-08       Impact factor: 5.082

6.  Prevention of venous thrombosis after total knee arthroplasty. Comparison of antithrombin III and low-dose heparin with dextran.

Authors:  C W Francis; V D Pellegrini; B N Stulberg; M L Miller; S Totterman; V J Marder
Journal:  J Bone Joint Surg Am       Date:  1990-08       Impact factor: 5.284

7.  Dose- and time-dependent antiplatelet effects of aspirin.

Authors:  Christina Perneby; N Håkan Wallén; Cathy Rooney; Desmond Fitzgerald; Paul Hjemdahl
Journal:  Thromb Haemost       Date:  2006-04       Impact factor: 5.249

Review 8.  Risk factors for venous thromboembolism after total hip and knee replacement surgery.

Authors:  Richard H White; Mark C Henderson
Journal:  Curr Opin Pulm Med       Date:  2002-09       Impact factor: 3.155

9.  Effect of different aspirin doses on platelet aggregation in patients with stable coronary artery disease.

Authors:  S Malhotra; Y P Sharma; A Grover; S Majumdar; S M Hanif; V K Bhargava; A Bhatnagar; P Pandhi
Journal:  Intern Med J       Date:  2003-08       Impact factor: 2.048

10.  Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

Authors:  Deborah M Siegal; John T Curnutte; Stuart J Connolly; Genmin Lu; Pamela B Conley; Brian L Wiens; Vandana S Mathur; Janice Castillo; Michele D Bronson; Janet M Leeds; Florie A Mar; Alex Gold; Mark A Crowther
Journal:  N Engl J Med       Date:  2015-11-11       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.